Affinity improvement of the high-affinity immunoglobulin E receptor by phage display. 2002

Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
Institute of Applied Biochemistry, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan.

The immunoglobulin E (IgE)-binding site of its high-affinity receptor is localized in the second immunoglobulin-like domain (D2) of the alpha-subunit (Fc epsilon RI alpha). In this study, the randomized pentapeptides were introduced between Glu(132) and Ile(138) of Fc epsilon RI alpha D2 and displayed on a filamentous phage. After eight rounds of panning, a phage clone having a mutation of Asp(135)Tyr(136)Met(137) in Fc epsilon RI alpha D2 was obtained. The binding affinity of the mutant phages to immobilized IgE was approximately 500 times higher than that of the wild type. The mutant phages competitively inhibited the binding of IgE to the soluble receptor at a 50% inhibition (IC(50)) value of 116 pM. The mutant Fc epsilon RI alpha D2, which had been expressed as a fusion protein with glutathione S-transferase in Escherichia coli, also showed higher IgE-binding capacity than the wild type. The mutant Fc epsilon RI alpha D2 is expected to manifest its improved IgE-binding affinity together with any fusion partner.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
January 1994, Chemical immunology,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
March 2005, Journal of molecular biology,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
January 1997, Human antibodies,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
January 1986, Annual review of immunology,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
January 1989, Sub-cellular biochemistry,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
May 2016, European journal of pharmacology,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
January 2009, Methods in molecular biology (Clifton, N.J.),
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
August 1993, FEBS letters,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
November 1991, Biochemistry,
Akio Iwasaki, and Takeshi Doi, and Michihisa Umetani, and Masanao Watanabe, and Makoto Suda, and Yukio Hattori, and Takao Nagoya
April 1999, Nature biotechnology,
Copied contents to your clipboard!